By Anuja Vaidya, Senior Editor
Published November 18, 2026
In a significant push to tighten fiscal accountability and safeguard taxpayer dollars, the Centers for Medicare & Medicaid Services (CMS) has unveiled a sweeping proposed rule aimed at fortifying fraud detection and prevention efforts across the nation’s largest public health programs. The proposal seeks to overhaul the regulatory framework governing Medicare, Medicaid, the Children’s Health Insurance Program (CHIP), and the Affordable Care Act (ACA) Marketplace, signaling a aggressive stance against systemic waste, fraud, and abuse.
The proposed regulations introduce rigorous new standards for provider enrollment, mandate the reporting of suspicious activities by private plan sponsors, and grant the agency enhanced authority to sever ties with bad actors. As the federal government grapples with persistent improper payment rates, these measures represent one of the most substantial attempts in recent years to secure the integrity of the U.S. healthcare safety net.
Main Facts: A Regulatory Overhaul
The proposed rule functions as a multi-pronged enforcement strategy. At its core, it grants CMS expanded "gatekeeping" powers, allowing the agency to deny or revoke Medicare enrollment for healthcare providers and medical equipment suppliers if their identities or operational locations cannot be definitively verified.
Beyond initial screening, the rule fundamentally shifts the responsibility of oversight onto private entities. Historically, Medicare Advantage (MA) organizations and Part D plan sponsors have been encouraged—but not legally required—to report suspected instances of fraud, waste, and abuse. Under the new proposal, this voluntary paradigm would be replaced by a mandatory reporting requirement.

The proposal also extends its reach to the ACA Marketplace, specifically targeting insurance agents and brokers. By establishing stricter bars for individuals with felony convictions and creating a mechanism to suspend brokers facing credible allegations of abuse, CMS aims to prevent the unauthorized switching of consumer plans—a recurring issue that has plagued the Marketplace in recent enrollment cycles.
Chronology of Regulatory Tension
The introduction of this rule arrives at a volatile time for federal healthcare administration. The timeline of events leading to this proposal highlights a growing frustration within CMS regarding the efficacy of existing oversight tools:
- Early 2025: CMS internal audits reveal that fewer than half of all Medicare Advantage and Part D plan contracts reported suspected fraud, and only 19% disclosed cases where they had suspended payments to suspicious providers.
- September 2026: In an effort to curb unauthorized enrollment activity, CMS imposed a surprise freeze on new ACA broker registrations.
- November 2026 (Early Month): A federal judge ruled against the CMS moratorium, striking down the registration freeze and forcing the agency to rethink its strategy for managing third-party agents.
- November 18, 2026: CMS officially publishes the new proposed rule, opting for a broad, systemic approach to fraud prevention rather than the targeted registration bans that faced judicial pushback.
- January 19, 2027: The deadline for public comment, marking the final window for industry stakeholders to weigh in before the rule moves toward finalization.
Supporting Data: The Cost of Improper Payments
The urgency behind the proposal is rooted in fiscal data released by the Department of Health and Human Services (HHS). On Monday, the agency confirmed that improper payments—defined as payments that do not meet program requirements, including overpayments, underpayments, and those lacking sufficient documentation—have remained stubbornly flat.
According to the latest CMS figures for Fiscal Year 2026, there have been slight, concerning increases in improper payment rates across Medicare, Medicaid, and CHIP. While federal officials emphasize that "improper" does not always equate to "fraud," the sheer volume of these payments suggests a critical lack of administrative control.
The data highlights a significant gap between the government’s goals for program integrity and the reality on the ground. By mandating that private plans report fraud, CMS hopes to leverage the eyes and ears of the private sector to bridge this gap, essentially offloading the heavy lifting of investigative monitoring onto the insurers who are closest to the billing process.

Official Responses and Industry Implications
The reaction from the healthcare sector has been cautious, as stakeholders prepare to digest the impact of increased compliance costs.
For Medicare Advantage plans, the requirement to report "suspected" fraud creates a legal and operational burden. Organizations will need to invest in advanced analytics and dedicated compliance staff to distinguish between administrative errors—which are common in the complex Medicare billing environment—and malicious fraud.
"The industry has long understood that the status quo is unsustainable," said one healthcare policy consultant, who requested anonymity. "However, the devil is in the details. By requiring reports on suspected fraud, CMS is effectively turning every insurance company into a field agent for the Office of Inspector General. The compliance burden on smaller, regional plans could be substantial."
State Medicaid programs are also facing a shift. The proposed rule mandates that states implement stricter criteria for provider enrollment, specifically citing felony convictions as a basis for termination. This represents a significant tightening of state-level autonomy, requiring states to update their internal databases and harmonize their reporting protocols with federal standards.
Implications: The Future of Healthcare Integrity
If finalized, this rule will alter the landscape of the healthcare industry in three distinct ways:

1. The Death of "Voluntary" Oversight
The transition from voluntary to mandatory reporting is a watershed moment. By formalizing this requirement, CMS is signaling that the era of "self-policing" among MA plans is over. Plans that fail to report could face contract sanctions, effectively putting their ability to operate at risk. This will likely lead to an influx of data into CMS, which the agency will then need to process and act upon—an operational challenge in itself.
2. Heightened Barriers for Providers
For providers, the new rules create a more rigorous enrollment environment. Suppliers, particularly in the durable medical equipment (DME) sector, will face increased scrutiny regarding their physical presence and ownership structures. This is a direct response to "shell company" schemes where fraudulent entities bill Medicare from non-existent locations.
3. A Battle Over Broker Accountability
The inclusion of ACA brokers in the rule highlights the ongoing friction between the government and third-party sales entities. By creating a federal mechanism to suspend brokers based on "credible abuse allegations," CMS is attempting to bypass the court-ordered restrictions that hindered their earlier, more heavy-handed registration freezes. This move will likely be challenged in court by trade groups representing brokers, who argue that such actions infringe on due process.
The Path Forward
The proposal is currently in the public comment phase, a critical period where industry lobbyists, patient advocacy groups, and state agencies will attempt to carve out exceptions or clarify the definitions of "suspected fraud."
As CMS moves toward the January 19 deadline, the broader takeaway is clear: the federal government is no longer content with passive oversight. Whether through improved data reporting, stricter provider vetting, or expanded authority over the ACA Marketplace, the agency is preparing to exert its influence to curb the rising tide of improper payments. For healthcare providers, insurers, and brokers alike, the message is one of increased transparency and accountability—a transformation that will undoubtedly define the next era of American healthcare policy.
